AGP Executive Report
Last update: 2 hours agoSleep Research: A Cochrane review of nine trials found medical cannabis, including THC and CBD products, offered little to no meaningful improvement for insomnia; dizziness and dry mouth were among reported side effects. Heart Health: A survey of nearly 500,000 U.S. adults linked cannabis use with higher reported cardiovascular disease and stroke risk, even among occasional users. The study shows an association, not proof of cause. Teen Health: Cannabis was involved in 84% of substance-related emergency visits and hospitalizations among 16- to 18-year-olds in a Washington University study. Federal Policy: Medical marijuana rescheduling faces a Nov. 5 filing deadline as critics, including former DEA chief Asa Hutchinson, call for stronger safeguards. Separately, the DEA has registered more than 900 medical cannabis dispensaries, potentially opening access to tax benefits. Hemp Rules: A federal ban on many hemp-derived products is due in December, raising concerns for CBD businesses and consumers. Nepal: The Supreme Court ordered the government to create rules for cannabis cultivation and production for medical, scientific and industrial uses within three months; it did not legalize recreational use.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
